Inno Dev
2008 (Cycle 17)
| Banning Butts: The Environmental Case | 2008 (Cycle 17) | $54,040 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Banning Butts: The Environmental Case | 2008 (Cycle 17) | $45,460 |
| San Diego State University Research Foundation | Public Health, Public Policy, and Economics | |
| Instant SHS Feedback as a Catalyst for Smoke-Free Homes | 2008 (Cycle 17) | $129,917 |
| San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
| Evaluating Mechanisms of Change in a Smoking Intervention | 2008 (Cycle 17) | $219,376 |
| RAND Corporation | Tobacco-Use Prevention and Cessation | |
2007 (Cycle 16)
| Fusion proteins that convert VEGF into a cell death factor | 2007 (Cycle 16) | $100,000 |
| University of California, San Francisco | Cancer | |
| Nicotine modifies cardiac growth during adolescence | 2007 (Cycle 16) | $128,358 |
| Veterans Medical Research Foundation | Cardiovascular Disease | |
| Computer Simulation as a Tool for Reducing SHS Exposure | 2007 (Cycle 16) | $113,549 |
| Education Training and Research Associates, Inc. | Tobacco-Use Prevention and Cessation | |
| Does nicotine exposure inhibit convective drug delivery? | 2007 (Cycle 16) | $119,692 |
| La Jolla Bioengineering Institute | Cancer | |
| Investigating College Student Cigarette Smoking Self-change | 2007 (Cycle 16) | $138,580 |
| Veterans Medical Research Foundation | Tobacco-Use Prevention and Cessation | |
2006 (Cycle 15)
| Social Smoking within College Drinking Environments | 2006 (Cycle 15) | $141,114 |
| San Diego State University Research Foundation | Epidemiology | |
| Novel Approaches to Lung Cancer Research | 2006 (Cycle 15) | $189,486 |
| The Burnham Institute for Medical Research | Cancer | |
| Nicotine Disrupts PTHrP-Driven Paracrine Signaling Globally | 2006 (Cycle 15) | $133,126 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | General Biomedical Science | |
| Mechanisms of Tobacco-Induced Retinal Neovascularization | 2006 (Cycle 15) | $155,211 |
| Stanford University | Cardiovascular Disease | |
2005 (Cycle 14)
| Effects of social capital on smoking: elasticity & pathways | 2005 (Cycle 14) | $98,854 |
| University of California, Berkeley | Public Health, Public Policy, and Economics | |
| Development of nicotine withdrawal measures | 2005 (Cycle 14) | $91,173 |
| Scripps Research Institute | Nicotine Dependence | |
| A novel, 3-dimensional approach to non-invasive diagnostics | 2005 (Cycle 14) | $99,000 |
| University of California, Irvine | Cancer | |
| Asthma, gender, and ETS: pathogenic synergy | 2005 (Cycle 14) | $98,908 |
| University of California, Davis | Pulmonary Disease | |
| Tobacco radioactivity & public health policy | 2005 (Cycle 14) | $154,367 |
| Cedars-Sinai Medical Center | Public Health, Public Policy, and Economics | |
| Development of nicotine withdrawal measures | 2005 (Cycle 14) | $50,956 |
| University of California, San Diego | Nicotine Dependence | |
| African American church role in tobacco norm change | 2005 (Cycle 14) | $115,098 |
| Health Education Council | Tobacco-Use Prevention and Cessation | |
| A mindfulness-based approach to relapse prevention | 2005 (Cycle 14) | $133,530 |
| California Pacific Medical Center Research Institute | Tobacco-Use Prevention and Cessation | |
2004 (Cycle 13)
| Does nicotine increase sprouting of pericyte tubes? | 2004 (Cycle 13) | $207,300 |
| La Jolla Institute for Molecular Medicine | Cardiovascular Disease | |
| Antiatherogenic helical segments of apoA-I | 2004 (Cycle 13) | $141,230 |
| Lawrence Berkeley National Laboratory | Cardiovascular Disease | |
| Secondhand smoke contamination and resale value | 2004 (Cycle 13) | $146,760 |
| San Diego State University Research Foundation | Epidemiology | |
| Airway transcriptome changes in smokers | 2004 (Cycle 13) | $99,500 |
| University of California, San Francisco | Pulmonary Disease | |
2003 (Cycle 12)
| A web-based support community as a tool for ST cessation | 2003 (Cycle 12) | $100,000 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| CSF biomarkers of brain metastases from lung cancer | 2003 (Cycle 12) | $100,000 |
| University of California, San Francisco | Cancer | |
| A novel FMRI smoking craving and reward paradigm | 2003 (Cycle 12) | $96,949 |
| University of California, Los Angeles | Nicotine Dependence | |
| Dietary fat and ETS effects on lung epithelial biology | 2003 (Cycle 12) | $99,827 |
| University of California, Davis | Pulmonary Disease | |
2002 (Cycle 11)
| Tobacco-altered tissue of the mouth may promote oral cancer | 2002 (Cycle 11) | $113,120 |
| Lawrence Berkeley National Laboratory | Cancer | |
| Isothiocyantes among African Americans and Caucasions | 2002 (Cycle 11) | $73,270 |
| University of California, Irvine | Epidemiology | |
| Effect of nicotine on fetal hemopoietic stem cell migration | 2002 (Cycle 11) | $152,352 |
| La Jolla Institute for Molecular Medicine | Cardiovascular Disease | |
| Mentholated cigarettes and risk of acute MI, CHD, and stroke | 2002 (Cycle 11) | $106,246 |
| Kaiser Foundation Research Institute | Epidemiology | |
2001 (Cycle 10)
| Measuring adolescent smoking cessation motives and methods | 2001 (Cycle 10) | $103,273 |
| Veterans Medical Research Foundation | Epidemiology | |
| Cigarette smoke effects on cells crucial for wound healing | 2001 (Cycle 10) | $74,500 |
| University of California, Riverside | General Biomedical Science | |
| Effect of cigarette smoking on pulmonary metastasis | 2001 (Cycle 10) | $36,236 |
| University of California, Davis | Cancer | |
| Exploring tobacco cessation services on CA college campuses | 2001 (Cycle 10) | $81,995 |
| Public Health Institute | Tobacco-Use Prevention and Cessation | |
| Overcoming drug resistance in small cell lung cancer | 2001 (Cycle 10) | $141,340 |
| The Burnham Institute for Medical Research | Cancer | |
2000 (Cycle 9)
| Regulation of MAP kinase signaling pathway in lung cancer | 2000 (Cycle 9) | $84,671 |
| University of California, San Diego | Cancer | |
| Diagnostic tools of HDL damage by tobacco smoke | 2000 (Cycle 9) | $113,878 |
| Lawrence Berkeley National Laboratory | Cardiovascular Disease | |
| Innovation to prevent post-partum relapse | 2000 (Cycle 9) | $75,000 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Chemopreventive strategies against lung cancer recurrence | 2000 (Cycle 9) | $75,000 |
| University of California, Los Angeles | Cancer | |
| Life histories: Chinese-American elders' smoking encounters | 2000 (Cycle 9) | $17,146 |
| Stanford University | Epidemiology | |
| The angiogenic role of interleukin-8 in lung cancer | 2000 (Cycle 9) | $152,785 |
| La Jolla Institute for Molecular Medicine | Cancer | |
| Role of released ATP in cardiovascular effects of nicotine | 2000 (Cycle 9) | $75,000 |
| University of California, San Diego | Cardiovascular Disease | |
| Development of a new device to measure ambulatory smoking | 2000 (Cycle 9) | $72,238 |
| University of California, Los Angeles | Public Health, Public Policy, and Economics | |
| Smoking and echogenicity of the arterial intima | 2000 (Cycle 9) | $119,299 |
| University of Southern California | Epidemiology | |
| A new molecular approach for predicting lung cancer | 2000 (Cycle 9) | $75,000 |
| University of California, Irvine | Cancer | |
| Cigarette smoking in HIV-positive populations | 2000 (Cycle 9) | $74,882 |
| University of California, San Francisco | Epidemiology | |
1999 (Cycle 8)
| Genetic links to nicotine addiction: ethics of testing teens | 1999 (Cycle 8) | $115,591 |
| Stanford University | Epidemiology | |
| Liposome targeted chemotherapy to treat lung cancer | 1999 (Cycle 8) | $75,000 |
| University of California, San Francisco | Pulmonary Disease | |
| IL-12 genetic immunotherapy for lung cancer | 1999 (Cycle 8) | $75,000 |
| University of California, Los Angeles | Cancer | |
| Pager-cued therapeutic messages for smoking cessation | 1999 (Cycle 8) | $74,889 |
| University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
| Smoking, gender, hormones and the brain | 1999 (Cycle 8) | $69,084 |
| University of California, Los Angeles | Nicotine Dependence | |
| Effect of secondhand smoke on pulmonary t cell recruitment | 1999 (Cycle 8) | $69,094 |
| University of California, Davis | Pulmonary Disease | |
| Co-regulator mechanisms in lung cancer | 1999 (Cycle 8) | $38,267 |
| University of California, San Diego | Cancer | |
| Hmong cultural practices and patterns of tobacco use | 1999 (Cycle 8) | $83,383 |
| California Health Collaborative | Epidemiology | |
| Smoke on bacterial interactions with airway epithelia | 1999 (Cycle 8) | $74,449 |
| University of California, Berkeley | Pulmonary Disease | |
| Monitoring exposure to tobacco-specific nitrosamines | 1999 (Cycle 8) | $74,999 |
| University of California, Riverside | Cancer | |
| A retroviral link to human tobacco-related lung cancer? | 1999 (Cycle 8) | $74,500 |
| University of California, Los Angeles | Cancer | |
1998 (Cycle 7)
| Nicotine replacement therapy: pharmacists' counseling role | 1998 (Cycle 7) | $113,929 |
| SRI International | Nicotine Dependence | |
| Passive smoking, metabolizing genes and female lung cancer | 1998 (Cycle 7) | $111,740 |
| Childrens Hospital, Los Angeles | Epidemiology | |
| The effect of nicotine and cigarette smoke on respiration | 1998 (Cycle 7) | $130,177 |
| Scripps Research Institute | Epidemiology | |
| Isolation of lung tumor proteins for a novel treatment | 1998 (Cycle 7) | $75,000 |
| University of California, San Diego | Cancer | |
| Early detection of oral cancer | 1998 (Cycle 7) | $74,901 |
| University of California, Irvine | Cancer | |
| Allocation of Health Care to Smokers: Practice and Ethics | 1998 (Cycle 7) | $113,598 |
| Stanford University | Public Health, Public Policy, and Economics | |
| Pilot test of a 3-D chat room for rural teen smokers | 1998 (Cycle 7) | $112,437 |
| San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
| Website as a medium for intervention in teen smoking | 1998 (Cycle 7) | $73,159 |
| University of California, San Diego | Tobacco-Use Prevention and Cessation | |
| Cigarette smoke effects on human vascular endothelial genes | 1998 (Cycle 7) | $75,000 |
| University of California, Riverside | Cardiovascular Disease | |
| Toxic compounds targeted to lung tumor blood vessels | 1998 (Cycle 7) | $144,300 |
| The Burnham Institute for Medical Research | Cancer | |
| Alternative sources of ETS exposure in infants | 1998 (Cycle 7) | $109,687 |
| San Diego State University Research Foundation | Epidemiology | |
| Discovery of serum markers of lung cancer | 1998 (Cycle 7) | $120,300 |
| Cedars-Sinai Medical Center | Cancer | |
1997 (Cycle 6)
| Effects of nicotine exposure in utero on brain cell death | 1997 (Cycle 6) | $74,499 |
| University of California, San Diego | General Biomedical Science | |
| Cholesterol metabolism and atherosclerosis | 1997 (Cycle 6) | $74,500 |
| University of California, San Diego | Cardiovascular Disease | |
| Macular pigment regeneration upon smoking cessation | 1997 (Cycle 6) | $74,988 |
| University of California, Berkeley | General Biomedical Science | |
| Role of immune defenses in lung cancer therapy | 1997 (Cycle 6) | $75,000 |
| University of California, San Francisco | Cancer | |
| A novel lung tumor suppressor | 1997 (Cycle 6) | $144,788 |
| The Burnham Institute for Medical Research | Cancer | |
| Plasma antioxidant enzymes as markers of smoke injury | 1997 (Cycle 6) | $123,073 |
| Lawrence Berkeley National Laboratory | Cardiovascular Disease | |
| Functional MRI of neural activation | 1997 (Cycle 6) | $48,447 |
| University of California, Los Angeles | Nicotine Dependence | |
| How do tobacco smoke compounds impair lung surfactant? | 1997 (Cycle 6) | $74,961 |
| University of California, Santa Barbara | Pulmonary Disease | |
| Effects of perinatal nicotine on the Brain | 1997 (Cycle 6) | $93,122 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Nicotine Dependence | |
| Bioactive lipids in tobacco related lung cancers | 1997 (Cycle 6) | $74,496 |
| University of California, San Diego | Cancer | |
1995 (Cycle 4)
| A New Approach for Studying the Mechanism of Squamous Metapl | 1995 (Cycle 4) | $75,000 |
| University of California, Los Angeles | Cancer | |
| Maternal Smoking Habit Modification Via Fetal Visualization | 1995 (Cycle 4) | $16,475 |
| Sharp HealthCare-Sharp Memorial Hospital | Tobacco-Use Prevention and Cessation | |
| Genetic Susceptibility to Lung Cancer | 1995 (Cycle 4) | $104,580 |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Epidemiology | |
| Smoking, Gender, Self-Selection & Absence from Work | 1995 (Cycle 4) | $55,306 |
| San Jose State University Foundation | Public Health, Public Policy, and Economics | |
| 2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth | 1995 (Cycle 4) | $149,221 |
| The Burnham Institute for Medical Research | Cardiovascular Disease | |
| Cloning of a Lung Tumor Transport Gene for Drug Development | 1995 (Cycle 4) | $104,966 |
| University of California, San Diego | Cancer | |
| Irritant & Analgesic Effects of Nicotine | 1995 (Cycle 4) | $75,000 |
| University of California, Davis | General Biomedical Science | |
| Preneoplastic Lesions and Polarity Changes in Lung Epithelia | 1995 (Cycle 4) | $142,731 |
| The Burnham Institute for Medical Research | Cancer | |
| Maternal Smoking Habit Modification Via Fetal Visualization | 1995 (Cycle 4) | $54,471 |
| University of California, San Diego | Tobacco-Use Prevention and Cessation | |
| Targeted Delivery of p53 to Lung Carcinoma Cells | 1995 (Cycle 4) | $143,150 |
| Sidney Kimmel Cancer Center | Cancer | |
| Tobacco Products, Activin-A, and Lung Cancers | 1995 (Cycle 4) | $122,583 |
| University of Southern California | Pulmonary Disease | |
1994 (Cycle 3)
| Gene Therapy for Emphysema | 1994 (Cycle 3) | $74,844 |
| University of California, San Francisco | Pulmonary Disease | |
| Smoker Macrophage Response to Mycobacteria | 1994 (Cycle 3) | $74,986 |
| University of California, San Diego | Pulmonary Disease | |
| The Effects of Cotinine on Human Information Processing | 1994 (Cycle 3) | $74,912 |
| University of California, San Francisco | Public Health, Public Policy, and Economics | |
| Interaction of Cadmium with Sickle Red Cells | 1994 (Cycle 3) | $17,363 |
| University of California, Berkeley | Cardiovascular Disease | |
| Tumor-Specific Vascular Proteins in Lung Cancer | 1994 (Cycle 3) | $75,000 |
| University of California, San Diego | Cancer | |
| The Role of TGF-B1 In Intimal Hyperplasia | 1994 (Cycle 3) | $66,448 |
| The Burnham Institute for Medical Research | Cardiovascular Disease | |
| Serum Free Fatty Acid Levels in Patients with Malignancies | 1994 (Cycle 3) | $107,728 |
| Medical Biology Institute | Cancer | |
| Environmental Tobacco Smoke & the Brain Growth Spurt | 1994 (Cycle 3) | $75,000 |
| University of California, Los Angeles | General Biomedical Science | |
| Can Computer Games Prevent Tobacco Use? | 1994 (Cycle 3) | $105,362 |
| Stanford University | Tobacco-Use Prevention and Cessation | |
1993 (Cycle 2)
| Long term patterns and consequences of tobacco use among.... | 1993 (Cycle 2) | $74,838 |
| University of California, Los Angeles | Public Health, Public Policy, and Economics | |
| Novel Hypoxic Cytotoxins To Enhance Lung Cancer Radiotherapy | 1993 (Cycle 2) | $152,412 |
| SRI International | Cancer | |
| Detection of Lung Cancer Micrometastases | 1993 (Cycle 2) | $120,346 |
| University of Southern California | Cancer | |
| Detection of Lung Tumor Derived DNA in Sputum Using PCR | 1993 (Cycle 2) | $115,098 |
| University of Southern California | Cancer | |
| An Idea for a Cohort Study of Tobacco-Related Cancers | 1993 (Cycle 2) | $73,428 |
| University of California, Los Angeles | Epidemiology | |
| Effects of Environmental Tobacco Smoke on Pulmonary Allergy | 1993 (Cycle 2) | $62,512 |
| University of California, Davis | Pulmonary Disease | |
| Human Markers for(S)-Nicotine Biotransformation & Pathology | 1993 (Cycle 2) | $58,899 |
| University of California, San Francisco | Nicotine Dependence | |
| Selective Lung Tumor Inhibition With 4-Ipomeanol Analogs | 1993 (Cycle 2) | $126,499 |
| Scripps Research Institute | Cancer | |
| Effect of Nicotine on Fibrinolytic Responsiveness in Vivo | 1993 (Cycle 2) | $69,941 |
| Scripps Research Institute | Cardiovascular Disease | |
| Antimicrobial Proteins of Human Alveolar Macrophages | 1993 (Cycle 2) | $71,549 |
| University of California, Los Angeles | Pulmonary Disease | |
| Polycyclic Aromatic Hydrocarbons and Hepatitis B Virus | 1993 (Cycle 2) | $75,000 |
| University of California, San Francisco | General Biomedical Science | |
| Assessing Organizational Influence on Chinese Smoking | 1993 (Cycle 2) | $75,150 |
| University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
| A Hypothalamic Mechanism of Nicotine Reward and Addiction | 1993 (Cycle 2) | $61,640 |
| University of California, San Diego | Nicotine Dependence | |
| Targeting of SCLC myc mRNA by Photoactivatable DNA Probes | 1993 (Cycle 2) | $108,353 |
| Beckman Research Institute of the City of Hope | Cancer | |
| Affect Regulation in the Prevention of Smoking Relapse | 1993 (Cycle 2) | $70,601 |
| Northern California Institute for Research & Education | Tobacco-Use Prevention and Cessation | |
| Chronic respiratory effects of past and passive smoking | 1993 (Cycle 2) | $121,461 |
| Loma Linda Preventive Medicine Medical Group, Inc. | Epidemiology | |